BioNTech SE (BNTX) Inventory Average (2019 - 2026)

BioNTech SE has reported Inventory Average for 6 years, with the latest figure at $196.4 million in Q4 2025.

• Quarterly Inventory Average fell 38.21% year-over-year to $196.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $196.4 million (down 38.21% YoY) and the FY2025 annual result came in at $213.9 million, down 37.78% from the prior year.
• Inventory Average eased to $196.4 million in Q4 2025 per BNTX's latest filing, from $262.5 million in the prior quarter.
• Over five years, Inventory Average peaked at $545.2 million in Q1 2022 and troughed at $126.8 million in Q1 2021.
• A 5-year average of $357.8 million and a median of $370.7 million in 2024 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2025: Inventory Average jumped 329.91% in 2022, then tumbled 38.21% in 2025.
• Over 5 years, Inventory Average stood at $126.8 million in 2021, then jumped by 194.04% to $372.9 million in 2022, then grew by 12.29% to $418.7 million in 2023, then slipped by 24.1% to $317.8 million in 2024, then slumped by 38.21% to $196.4 million in 2025.
• According to Business Quant data, Inventory Average over the past three periods registered $196.4 million, $262.5 million, and $264.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.